In the present study, CHD patients with the LRP5 rs556442 GG genotype had an increased risk of developing NAFLD, which indicates that detection of the LRP5 rs556442 GG genotype should be included in NAFLD screening efforts in CHD patients. Here, LRP5 is linked to coronary artery disorder.